Cosmo Pharmaceuticals N.V. (COPN.SW) SIX

57.00

-0.1(-0.18%)

Updated at August 19 10:38AM

Currency In CHF

Valuation

Market Cap1.11B
Enterprise Value1.07B
P/E Ratio7.46
PEG Ratio0.08
Price/Sales Ratio3.63
Price/Book Ratio1.99
Enterprise/Revenue3.47
Enterprise/EBITDA5.59

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin0.5
Operating Margin0.56

Management Effectiveness

Return On Assets0.21
Return On Equity0.27

Income Statement

Revenue266.79M
Revenue/Share16.31
Gross Profit246.92M
EBITDA165.71M
Net Income133.24M
Diluted EPS8.12

Balance Sheet

Total Cash142.96M
Total Cash/Share8.74
Total Debt2.2M
Total Debt/Equity0
Current Ratio4.19
Book Value Per Share30.88

Price History

52-Week Change-27.13
52-Week High80.6
52-Week Low41.6
Moving Average 50 Days59.07
Moving Average 200 Days59.02

Statistics

Average Volume23,918
Shares Outstanding15.94M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1.92
Trailing Annual Dividend Yield3.16
Payout Ratio0.24
Last Split FactorN/A
Last Split DateN/A